Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth

• Mira Jung ,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Resources, Supervision, Validation, Writing – original draft

  * E-mail: jungm@georgetown.edu

  Affiliation Department of Radiation Medicine, Georgetown University School of Medicine, Washington, DC, United States of America

  https://orcid.org/0000-0001-7146-5217

  ⨯
• Nicole Nicholas,

  Roles Formal analysis, Investigation

  Affiliation Department of Biochemistry & Molecular & Cellular Biology, Georgetown University School of Medicine, Washington, DC, United States of America

  ⨯
• Scott Grindrod,

  Roles Conceptualization, Formal analysis, Investigation

  Affiliation Shuttle Pharmaceuticals, Inc., Rockville, Maryland, United States of America

  ⨯
• Anatoly Dritschilo

  Roles Conceptualization, Resources, Writing – review & editing

  Affiliations Department of Radiation Medicine, Georgetown University School of Medicine, Washington, DC, United States of America, Shuttle Pharmaceuticals, Inc., Rockville, Maryland, United States of America

  ⨯